Need help now? Free crisis lines and helplines, worldwide — chapter 02 →
0 results for

Nutrients — Vitamins, Minerals, Protein, Fats, Sugars & Fibre: Benefits, Deficiencies & Harms

Category 16 of 20 in chapter 17, The Research Behind It, of Notbroken's Free Metabolic & Mental Health Help Directory: 16 listings, each carefully picked (listed, not endorsed). All 280 listings in The Research Behind It · Open the full directory of 2299 listings.
16
Listings
16 / 20
Category
17 / 18
Chapter
Latest Edition Always download the most up-to-date version, free, at notbroken.io
Know someone who could benefit? Share this guide with them.
Free to use · No account needed
Navigation
Contents
17
The Research Behind It — Free Papers on Chronic Disease and What the Evidence Shows
THE EVIDENCE
THE EVIDENCE

The Research Behind It — Free Papers on Chronic Disease and What the Evidence Shows

Why would a support group, a walking club, a low-carb book or an online CBT course help — and what drives chronic illness in the first place? This chapter gathers the research behind each part of the directory, and the research on causes: metabolic therapies, the nutrients in food, plastics and pollution, stress and trauma, the microbiome, and damp and mould. That is 280 studies, reviews and clinical guidelines, every one free to read and download in full, permanently and without a login. Most are kept in PubMed Central, the US National Library of Medicine's public archive; the rest are open access at the publisher, or free guidance from the World Health Organization and NICE. Each entry says what was found, why it matters here — which listings it backs up, or what it explains about chronic disease — and how strong the evidence is: strong (systematic reviews and guidelines with consistent findings), moderate (smaller or lower-certainty reviews, single large trials and large cohort studies) or early (pilot, cross-sectional and laboratory studies — promising, not proof). Studies that follow people over time show links, not proof of cause, and the entries say so. Where a study was funded by a company, or its authors run a listed programme, the note says so; where a listed book or service was not itself tested, the entry says it backs the approach rather than the product. Research moves on, so read these as good reasons to try something, not guarantees — and talk to your own clinician before changing a treatment or a medicine. Every paper was checked at least twice: by the researcher who chose it and again, independently, against its abstract and full text (the first 186 a third time); its public record was checked for corrections, retractions and expressions of concern (none is retracted), every number was looked up in the full text, and every link was opened in a browser.

Nutrients — Vitamins, Minerals, Protein, Fats, Sugars & Fibre: Benefits, Deficiencies & Harms

Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 — GBD 2017 Diet Collaborators, Lancet 2019

Global modelling study (comparative risk assessment) — 15 dietary factors in adults aged 25+ across 195 countries, using risk estimates from meta-analyses of cohort studies. Moderate evidence. Lancet 2019;393(10184):1958–1972. DOI 10.1016/S0140-6736(19)30041-8. Free full text in PubMed Central (PMC6899507) — open access, CC BY 4.0. Note: Modelled from observational studies, so these are links, not proof of cause; the later GBD 2019 analysis, using updated methods, put diet-linked deaths lower, at about 8 million in 2019.
What It Found
Estimated how much chronic disease worldwide is linked to 15 dietary factors. In 2017, 11 million adult deaths (22% of all adult deaths) and 255 million disability-adjusted life-years were attributed to dietary risks, mainly through cardiovascular disease (10 million deaths), then cancers and type 2 diabetes. The leading risks were a diet high in sodium (3 million deaths), low in whole grains (3 million) and low in fruit (2 million).
Why It Matters Here
Explains why everyday diet quality matters for chronic disease: too much salt and too few whole grains and fruit carried the largest diet-linked toll. The cooking classes and food communities in chapter 14, the eating-well resources in chapter 10 and the dietitian finders in chapter 15 can help.
Global modelling study (comparative risk assessment) — 15 dietary factors in adults aged 25+ across 195 countries, using risk estimates from meta-analyses of cohort studies. Moderate evidence. Lancet 2019;393(10184):1958–1972. DOI 10.1016/S0140-6736(19)30041-8. Free full text in PubMed Central (PMC6899507) — open access, CC BY 4.0. Note: Modelled from observational studies, so these are links, not proof of cause; the later GBD 2019 analysis, using updated methods, put diet-linked deaths lower, at about 8 million in 2019.

Carbohydrate intake for adults and children: WHO guideline — WHO 2023

WHO guideline — GRADE-rated systematic reviews of trials and cohort studies (fibre: 100 cohort studies and 49 trials in adults). Strong evidence. Geneva: World Health Organization; 2023. ISBN 978-92-4-007359-3. Free from the World Health Organization — open access, CC BY-NC-SA 3.0 IGO. Note: The disease links come from observational studies (moderate certainty); trials mainly measured risk factors such as weight and cholesterol.
What It Found
In cohort studies pooled for this WHO guideline, adults eating the most fibre had lower risks than those eating the least: death from any cause 15% lower (RR 0.85), coronary heart disease 24% lower (RR 0.76), type 2 diabetes and colorectal cancer each 16% lower (RR 0.84), all moderate certainty. WHO strongly recommends carbohydrate mainly from whole grains, vegetables, fruit and pulses, and at least 25 g of fibre a day for adults; it sets no total-carbohydrate target.
Why It Matters Here
Backs up the cooking classes and food programmes in chapter 14, the cooking and eating-well resources in chapter 10 and the dietitian finders in chapter 15: it sets out why fibre-rich whole foods matter for heart disease, diabetes and bowel cancer.
WHO guideline — GRADE-rated systematic reviews of trials and cohort studies (fibre: 100 cohort studies and 49 trials in adults). Strong evidence. Geneva: World Health Organization; 2023. ISBN 978-92-4-007359-3. Free from the World Health Organization — open access, CC BY-NC-SA 3.0 IGO. Note: The disease links come from observational studies (moderate certainty); trials mainly measured risk factors such as weight and cholesterol.

Guideline: sugars intake for adults and children — WHO 2015

WHO guideline — GRADE-rated systematic reviews of trials and cohort studies on body weight and dental caries. Moderate evidence. Geneva: World Health Organization; 2015. ISBN 978-92-4-154902-8. Free from the World Health Organization. Note: The guideline only weighed body weight and tooth decay; the stricter 5% suggestion rests on very low-quality evidence.
What It Found
WHO strongly recommends keeping free sugars (sugars added to food and drink, plus those in honey, syrups and fruit juice) below 10% of daily energy, and suggests below 5%. In trials, adults who cut free sugars lost a little weight (−0.80 kg) and those who added them gained (+0.75 kg), because of the extra energy rather than sugar as such. In cohort studies of children, more free sugars was linked with more tooth decay. The 10% advice rests on moderate-quality evidence.
Why It Matters Here
Backs up the advice to cut added sugar in metabolic-health books in chapter 10, such as The Obesity Code, and the recipe sites there that avoid refined sugar: cutting free sugars is a WHO recommendation for people of all ages.
WHO guideline — GRADE-rated systematic reviews of trials and cohort studies on body weight and dental caries. Moderate evidence. Geneva: World Health Organization; 2015. ISBN 978-92-4-154902-8. Free from the World Health Organization. Note: The guideline only weighed body weight and tooth decay; the stricter 5% suggestion rests on very low-quality evidence.

Reduction in saturated fat intake for cardiovascular disease — Hooper et al., Cochrane Database Syst Rev 2020

Cochrane systematic review and meta-analysis — 15 randomised trials, 56,675 people. Strong evidence. Cochrane Database Syst Rev 2020;8:CD011737. DOI 10.1002/14651858.CD011737.pub3. Free full text in PubMed Central (PMC8092457). Note: Saturated fat remains debated: the benefit was fewer combined heart and stroke events, with little or no effect on deaths, and trials varied widely.
What It Found
Pooled 15 randomised trials (56,675 people) that reduced saturated fat for at least two years. Cutting saturated fat lowered combined cardiovascular events by 17% (RR 0.83, 95% CI 0.70–0.98; moderate-quality evidence), with bigger cuts giving bigger benefit; replacing it with polyunsaturated fat or carbohydrate both looked useful. It made little or no difference to deaths from any cause (RR 0.96) or cardiovascular deaths (RR 0.95).
Why It Matters Here
Explains what randomised trials show about saturated fat and heart disease — useful context for readers of the high-fat keto, carnivore and low-carb communities. The dietitian finders in chapter 15 can help people change the fats they eat.
Cochrane systematic review and meta-analysis — 15 randomised trials, 56,675 people. Strong evidence. Cochrane Database Syst Rev 2020;8:CD011737. DOI 10.1002/14651858.CD011737.pub3. Free full text in PubMed Central (PMC8092457). Note: Saturated fat remains debated: the benefit was fewer combined heart and stroke events, with little or no effect on deaths, and trials varied widely.

Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women — Brand et al., Cochrane Database Syst Rev 2022

Cochrane systematic review and meta-analysis — 26 randomised trials, 34,961 adults and 92 children. Strong evidence. Cochrane Database Syst Rev 2022;8:CD015207. DOI 10.1002/14651858.CD015207. Free full text in PubMed Central (PMC9363242) — open access, CC BY. Note: Effects were small; trials left out people at risk of high potassium (e.g. kidney disease or some medicines), so safety for them is not established.
What It Found
Pooled 26 randomised trials in which people or households swapped regular salt for low-sodium salt substitutes, mostly potassium-enriched. In adults, substitutes probably lowered blood pressure slightly (systolic −4.76 mmHg, diastolic −2.43 mmHg) and probably slightly reduced non-fatal stroke, acute coronary syndrome and cardiovascular deaths (moderate certainty), while slightly raising blood potassium. Evidence in children was very uncertain.
Why It Matters Here
Explains one simple, tested way to eat less sodium and more potassium at home, relevant to the cooking communities in chapter 14 and the cooking and eating-well resources in chapter 10. All trials excluded people for whom extra potassium could be harmful, such as some with kidney disease.
Cochrane systematic review and meta-analysis — 26 randomised trials, 34,961 adults and 92 children. Strong evidence. Cochrane Database Syst Rev 2022;8:CD015207. DOI 10.1002/14651858.CD015207. Free full text in PubMed Central (PMC9363242) — open access, CC BY. Note: Effects were small; trials left out people at risk of high potassium (e.g. kidney disease or some medicines), so safety for them is not established.

Dietary intake of total, animal, and plant proteins and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of prospective cohort studies — Naghshi et al., BMJ 2020

Systematic review and dose–response meta-analysis — 32 prospective cohort studies, 715,128 people. Moderate evidence. BMJ 2020;370:m2412. DOI 10.1136/bmj.m2412. Free full text in PubMed Central (PMC7374797) — open access, CC BY 4.0. Note: Observational studies only, so these are links rather than proof of cause; results varied between studies and diet was mostly self-reported.
What It Found
Pooled 32 cohort studies (715,128 people, 113,039 deaths). Higher total protein intake was linked with a 6% lower risk of death from any cause (0.94, 95% CI 0.89–0.99), and higher plant protein with lower all-cause (0.92) and cardiovascular (0.88) death. Animal protein showed no significant link either way with death from any cause, cardiovascular disease or cancer. Each extra 3% of daily energy from plant protein was linked with 5% lower all-cause mortality.
Why It Matters Here
Explains how protein sources relate to long-term health — relevant to the carnivore, keto and plant-based communities in chapter 14 and to people using the protein-tracking apps in chapters 13 and 16.
Systematic review and dose–response meta-analysis — 32 prospective cohort studies, 715,128 people. Moderate evidence. BMJ 2020;370:m2412. DOI 10.1136/bmj.m2412. Free full text in PubMed Central (PMC7374797) — open access, CC BY 4.0. Note: Observational studies only, so these are links rather than proof of cause; results varied between studies and diet was mostly self-reported.

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease — Abdelhamid et al., Cochrane Database Syst Rev 2020

Cochrane systematic review and meta-analysis — 86 randomised trials, 162,796 people. Strong evidence. Cochrane Database Syst Rev 2020;3:CD003177. DOI 10.1002/14651858.CD003177.pub5. Free full text in PubMed Central (PMC7049091). Note: Most trials tested capsules; there was little trial evidence on eating oily fish itself.
What It Found
Pooled 86 randomised trials (162,796 people), mostly of fish-oil (long-chain omega-3) capsules, lasting 1–7 years. More long-chain omega-3 made little or no difference to death from any cause (RR 0.97; high certainty), cardiovascular events (RR 0.96; high certainty) or stroke, and may slightly reduce coronary heart disease events (RR 0.91; low certainty). More plant omega-3 (ALA) probably makes little or no difference to deaths.
Why It Matters Here
Explains that omega-3 capsules made little or no difference to deaths or overall cardiovascular events in trials — useful context when weighing supplements suggested by practitioners, clinics or retreats. The dietitian finders in chapter 15 can advise on omega-3 from food.
Cochrane systematic review and meta-analysis — 86 randomised trials, 162,796 people. Strong evidence. Cochrane Database Syst Rev 2020;3:CD003177. DOI 10.1002/14651858.CD003177.pub5. Free full text in PubMed Central (PMC7049091). Note: Most trials tested capsules; there was little trial evidence on eating oily fish itself.

Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose–response meta-analysis of prospective cohort studies — Fang et al., BMC Med 2016

Dose–response meta-analysis — 40 prospective cohort studies, more than 1 million people. Moderate evidence. BMC Med 2016;14:210. DOI 10.1186/s12916-016-0742-z. Free full text in PubMed Central (PMC5143460) — open access, CC BY 4.0. Note: Observational studies of diet, not supplement trials, so other features of magnesium-rich diets may explain part of the links.
What It Found
Pooled 40 cohort studies of more than 1 million people followed for 4–30 years. Each extra 100 mg a day of dietary magnesium was linked with a 19% lower risk of type 2 diabetes (RR 0.81), 22% lower heart failure (RR 0.78), 7% lower stroke (RR 0.93) and 10% lower death from any cause (RR 0.90), but not with total cardiovascular disease or coronary heart disease.
Why It Matters Here
Explains links between magnesium-rich eating (whole grains, green leafy vegetables and nuts) and chronic disease. The nutrient-tracking apps in chapter 16, such as Cronometer, and the dietitian finders in chapter 15 can help people check their intake.
Dose–response meta-analysis — 40 prospective cohort studies, more than 1 million people. Moderate evidence. BMC Med 2016;14:210. DOI 10.1186/s12916-016-0742-z. Free full text in PubMed Central (PMC5143460) — open access, CC BY 4.0. Note: Observational studies of diet, not supplement trials, so other features of magnesium-rich diets may explain part of the links.

Daily iron supplementation for improving anaemia, iron status and health in menstruating women — Low et al., Cochrane Database Syst Rev 2016

Cochrane systematic review and meta-analysis — 67 trials (randomised or quasi-randomised), 8,506 women. Strong evidence. Cochrane Database Syst Rev 2016;4:CD009747. DOI 10.1002/14651858.CD009747.pub2. Free full text in PubMed Central (PMC10182438). Note: Most trials were small with unclear methods; the fatigue findings came from separate trials with mixed results that were not pooled.
What It Found
Pooled 67 trials (8,506 menstruating women) of daily iron supplements. Iron cut the chance of being anaemic at the end of treatment by 61% (RR 0.39; moderate quality), raised haemoglobin (high quality) and reduced iron deficiency (RR 0.62). It improved exercise performance and appeared to reduce symptomatic fatigue, though fatigue data could not be pooled. Constipation and loose stools were about twice as common with iron.
Why It Matters Here
Explains what daily iron supplements do for women who menstruate, a group in which iron deficiency and anaemia are common worldwide — useful background for readers with ongoing tiredness, which has many possible causes. Testing and treatment belong with a doctor.
Cochrane systematic review and meta-analysis — 67 trials (randomised or quasi-randomised), 8,506 women. Strong evidence. Cochrane Database Syst Rev 2016;4:CD009747. DOI 10.1002/14651858.CD009747.pub2. Free full text in PubMed Central (PMC10182438). Note: Most trials were small with unclear methods; the fatigue findings came from separate trials with mixed results that were not pooled.

What Endocrinologists Should Know About Iodine: Population Deficiency, Individual Excess and Misinformation in the United Kingdom — Taylor et al., Clin Endocrinol (Oxf) 2026

Narrative expert review by UK thyroid and nutrition specialists. Moderate evidence. Clin Endocrinol (Oxf) 2026;105(5):523–530. DOI 10.1111/cen.70162. Free full text in PubMed Central (PMC13629602) — open access, CC BY 4.0. Note: A narrative review focused on the UK, where salt is not iodised; iodine status differs by country.
What It Found
UK thyroid and nutrition experts review the return of mild-to-moderate iodine deficiency: the 2019–2023 national survey found a median urinary iodine of 82 µg/L in women aged 16–49, below the WHO adequacy level. Risks include avoiding dairy, eating little fish, unfortified plant milks (only 28% are fortified) and sea or Himalayan salt, which has negligible iodine. They warn that kelp supplements and 'iodine resets' can deliver far too much iodine and trigger thyroid problems.
Why It Matters Here
Explains why vegans, people avoiding dairy and people with very restricted eating (including some neurodivergent people) can run short of iodine — relevant to the plant-based communities in chapter 14, the neurodiversity resources in chapter 09, the thyroid foundation in chapter 06 and dietitians in chapter 15.
Narrative expert review by UK thyroid and nutrition specialists. Moderate evidence. Clin Endocrinol (Oxf) 2026;105(5):523–530. DOI 10.1111/cen.70162. Free full text in PubMed Central (PMC13629602) — open access, CC BY 4.0. Note: A narrative review focused on the UK, where salt is not iodised; iodine status differs by country.

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study — Aroda et al., J Clin Endocrinol Metab 2016

Secondary analysis of a randomised trial (Diabetes Prevention Program) and its open-label follow-up — 2,155 people; vitamin B12 measured at 5 and 13 years. Moderate evidence. J Clin Endocrinol Metab 2016;101(4):1754–1761. DOI 10.1210/jc.2015-3754. Free full text in PubMed Central (PMC4880159). Note: B12 was measured only in people with stored blood samples; anaemia was more common with metformin but was not related to B12 status.
What It Found
Adults at high risk of type 2 diabetes were randomised to metformin or placebo, and the metformin group kept taking it for about 9 more years. Low or borderline-low vitamin B12 was more common with metformin at 5 years (19.1% vs 9.5%) and 13 years (20.3% vs 15.6%), and each year of metformin use was linked with 13% higher odds of B12 deficiency. Anaemia was more common with metformin, and nerve damage (neuropathy) was more common in metformin users with low B12.
Why It Matters Here
Explains that long-term metformin, widely used for prediabetes and type 2 diabetes, can lower vitamin B12 — worth knowing for readers of the metabolic-health resources in chapters 01 and 16 (the CDC National Diabetes Prevention Program in chapter 16 grew out of this trial).
Secondary analysis of a randomised trial (Diabetes Prevention Program) and its open-label follow-up — 2,155 people; vitamin B12 measured at 5 and 13 years. Moderate evidence. J Clin Endocrinol Metab 2016;101(4):1754–1761. DOI 10.1210/jc.2015-3754. Free full text in PubMed Central (PMC4880159). Note: B12 was measured only in people with stored blood samples; anaemia was more common with metformin but was not related to B12 status.

Effects and safety of periconceptional oral folate supplementation for preventing birth defects — De-Regil et al., Cochrane Database Syst Rev 2015

Cochrane systematic review and meta-analysis — 5 randomised trials, 7,391 women. Strong evidence. Cochrane Database Syst Rev 2015;(12):CD007950. DOI 10.1002/14651858.CD007950.pub3. Free full text in PubMed Central (PMC8783750). Note: The benefit is specific to neural tube defects; the trials are older and most reported their methods unclearly.
What It Found
Pooled 5 randomised trials (7,391 women) of folic acid taken around conception and in early pregnancy. Folic acid, alone or with other vitamins and minerals, cut neural tube defects such as spina bifida by about two-thirds (RR 0.31, 95% CI 0.17–0.58; 6,708 births; high-quality evidence), including repeat cases in women with a previously affected pregnancy. There was no clear effect on other birth defects or on miscarriage.
Why It Matters Here
Explains one of the clearest nutrient benefits shown in trials, relevant to anyone who could become pregnant. The trials tested folic acid supplements, not diet alone; a doctor, pharmacist or the dietitian finders in chapter 15 can advise.
Cochrane systematic review and meta-analysis — 5 randomised trials, 7,391 women. Strong evidence. Cochrane Database Syst Rev 2015;(12):CD007950. DOI 10.1002/14651858.CD007950.pub3. Free full text in PubMed Central (PMC8783750). Note: The benefit is specific to neural tube defects; the trials are older and most reported their methods unclearly.

Homocysteine-lowering interventions for preventing cardiovascular events — Martí-Carvajal et al., Cochrane Database Syst Rev 2017

Cochrane systematic review and meta-analysis — 15 randomised trials, 71,422 people. Strong evidence. Cochrane Database Syst Rev 2017;8:CD006612. DOI 10.1002/14651858.CD006612.pub5. Free full text in PubMed Central (PMC6483699). Note: The stroke benefit was small (4.3% vs 5.1%), and trials differed in participants, vitamin doses and access to folic-acid-fortified foods.
What It Found
Pooled 15 randomised trials (71,422 people) of vitamin B6, B9 (folic acid) and/or B12 supplements given to lower blood homocysteine, a marker linked with heart disease. Compared with placebo they made no difference to heart attacks (RR 1.02) or death from any cause (RR 1.01), both high-quality evidence, but stroke was slightly less common (4.3% vs 5.1%; RR 0.90). Serious adverse events did not differ.
Why It Matters Here
Explains that lowering homocysteine with B-vitamin pills did not prevent heart attacks or deaths — useful context when a practitioner or wellness programme suggests B-vitamin pills to lower homocysteine for heart health.
Cochrane systematic review and meta-analysis — 15 randomised trials, 71,422 people. Strong evidence. Cochrane Database Syst Rev 2017;8:CD006612. DOI 10.1002/14651858.CD006612.pub5. Free full text in PubMed Central (PMC6483699). Note: The stroke benefit was small (4.3% vs 5.1%), and trials differed in participants, vitamin doses and access to folic-acid-fortified foods.

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease — Manson et al., N Engl J Med 2019

Randomised placebo-controlled trial (VITAL) — 25,871 US adults (men 50+, women 55+), median 5.3 years. Moderate evidence. N Engl J Med 2019;380(1):33–44. DOI 10.1056/NEJMoa1809944. Free full text in PubMed Central (PMC6425757). Note: Most participants were not deficient (mean 25(OH)D 30.8 ng/mL; 12.7% below 20 ng/mL), so results may differ for people with low vitamin D.
What It Found
A large randomised trial gave daily vitamin D3 or placebo to 25,871 US adults not selected for deficiency, for a median of 5.3 years. Vitamin D did not reduce invasive cancer (HR 0.96, 95% CI 0.88–1.06) or major cardiovascular events (HR 0.97, 0.85–1.12), and deaths from any cause were similar (HR 0.99). An analysis not planned in advance hinted at fewer cancer deaths after the first one to two years. No excess of high calcium or kidney stones was seen.
Why It Matters Here
Explains that vitamin D pills did not prevent cancer or heart disease in generally healthy older adults — useful context when weighing supplements suggested by practitioners or wellness programmes. It does not test treatment of diagnosed deficiency.
Randomised placebo-controlled trial (VITAL) — 25,871 US adults (men 50+, women 55+), median 5.3 years. Moderate evidence. N Engl J Med 2019;380(1):33–44. DOI 10.1056/NEJMoa1809944. Free full text in PubMed Central (PMC6425757). Note: Most participants were not deficient (mean 25(OH)D 30.8 ng/mL; 12.7% below 20 ng/mL), so results may differ for people with low vitamin D.

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases — Bjelakovic et al., Cochrane Database Syst Rev 2012

Cochrane systematic review and meta-analysis — 78 randomised trials, 296,707 people. Strong evidence. Cochrane Database Syst Rev 2012;(3):CD007176. DOI 10.1002/14651858.CD007176.pub2. Free full text in PubMed Central (PMC8407395). Note: The excess deaths were small and showed up only in some analyses; the review dates from 2012 and studied supplements, not antioxidant-rich foods.
What It Found
Pooled 78 randomised trials (296,707 people) of beta-carotene, vitamin A, vitamin C, vitamin E and selenium supplements, in healthy people and people with stable disease. Overall they did not lower deaths (RR 1.02, 95% CI 0.98–1.05). In the 56 trials at low risk of bias, deaths were slightly higher with supplements (RR 1.04), driven by beta-carotene (RR 1.05) and vitamin E (RR 1.03); vitamin A, vitamin C and selenium had no significant effect.
Why It Matters Here
Explains why more is not always better with supplements: antioxidant pills did not lengthen life in trials, and some were linked with slightly more deaths — useful context when weighing supplement protocols offered by clinics, retreats or online programmes.
Cochrane systematic review and meta-analysis — 78 randomised trials, 296,707 people. Strong evidence. Cochrane Database Syst Rev 2012;(3):CD007176. DOI 10.1002/14651858.CD007176.pub2. Free full text in PubMed Central (PMC8407395). Note: The excess deaths were small and showed up only in some analyses; the review dates from 2012 and studied supplements, not antioxidant-rich foods.

Calcium intake and risk of fracture: systematic review — Bolland et al., BMJ 2015

Systematic review and meta-analysis — 26 randomised trials of calcium supplements, plus 2 trials and 44 cohort studies of dietary calcium, in people over 50. Moderate evidence. BMJ 2015;351:h4580. DOI 10.1136/bmj.h4580. Free full text in PubMed Central (PMC4784799) — open access, CC BY-NC 4.0. Note: Evidence on dietary calcium is observational; the supplement benefit shrank to nothing in the best-designed trials and the authors found signs of publication bias.
What It Found
Reviewed studies of calcium and fractures in people over 50. Most of the 44 cohort studies found no link between dietary calcium, milk or dairy intake and fracture risk, and no trial showed that more dietary calcium prevents fractures. In 26 trials, calcium supplements reduced total fractures by 11% (RR 0.89) and vertebral fractures slightly, but not hip or forearm fractures; in the four trials at lowest risk of bias there was no effect at any site.
Why It Matters Here
Explains that eating more calcium was not linked with fewer fractures and that calcium pills gave weak, inconsistent protection — useful context when bone-health supplements are suggested by practitioners or wellness programmes.
Systematic review and meta-analysis — 26 randomised trials of calcium supplements, plus 2 trials and 44 cohort studies of dietary calcium, in people over 50. Moderate evidence. BMJ 2015;351:h4580. DOI 10.1136/bmj.h4580. Free full text in PubMed Central (PMC4784799) — open access, CC BY-NC 4.0. Note: Evidence on dietary calcium is observational; the supplement benefit shrank to nothing in the best-designed trials and the authors found signs of publication bias.
Important Disclaimer
This directory is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making changes to your medication regimen or starting any new therapy.

This document does not guarantee the legitimacy, quality, or suitability of any business, organization, or practitioner listed within. The inclusion of any listing does not constitute an endorsement, recommendation, or verification of credentials. All organizations listed are independent entities over which the creators of this directory have no control or oversight.

This directory is intended to be used as a starting point and reference for the reader to conduct their own research, exercise their own judgment, and apply their own discretion before engaging with any listed organization or professional. Readers are strongly encouraged to independently verify credentials, read reviews, check licensing, and confirm current pricing and availability directly with each organization before committing to any services.

Costs, availability, contact details, and services may change at any time without notice. Information was accurate to the best of our knowledge at the time of publication.

About Notbroken.io: this directory and the accompanying Breathe, Calm, Sleep, Move, Eat, Track and Build tools were created by Nathan Leary, who runs and updates them. How each tool works, its safety notes, the privacy policy and terms of use are at notbroken.io/about, notbroken.io/privacy and notbroken.io/terms. The tools are general wellness aids, not medical devices, and Track is a personal journal that never gives medication advice.

If you are in crisis: Please contact your local emergency services immediately, or reach out to one of the following helplines:

International: Chapter 02 of this directory lists free helplines by situation and country; elsewhere use Find A Helpline — findahelpline.com
United States: 988 Suicide & Crisis Lifeline (call or text 988) • Crisis Text Line (text HOME to 741741)
United Kingdom: Samaritans — 116 123 (free, 24/7)
Canada: Talk Suicide Canada — 988 (call or text, 24/7)
Australia: Lifeline — 13 11 14 (24/7) • Beyond Blue — 1300 22 4636
New Zealand: Need to Talk? — 1737 (free, 24/7)
Europe: European Emergency Number — 112
India: iCall — 9152987821 • Vandrevala Foundation — 1860 2662 345
Singapore: Samaritans of Singapore — 1-767 (24/7)
Japan: TELL Lifeline — 03-5774-0992

No matches found

Nothing matched . Try broadening your search — remove a filter, use a single keyword, describe what you need in a sentence, or browse by a condition, a place, or a type of support.

Suggest a resource